About Haemonetics Corp. 
Haemonetics Corp.
Pharmaceuticals & Biotechnology
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.
Company Coordinates 
Company Details
125 SUMMER STREET , BOSTON MA : 02110
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 113 Schemes (52.28%)
Foreign Institutions
Held by 153 Foreign Institutions (14.09%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Richard Meelia
Independent Chairman of the Board
Mr. Christopher Simon
President, Chief Executive Officer, Director
Mr. Robert Abernathy
Independent Director
Ms. Catherine Burzik
Independent Director
Mr. Michael Coyle
Independent Director
Mr. Charles Dockendorff
Independent Director
Dr. Mark Kroll
Independent Director
Revenue and Profits:
Net Sales:
321 Million
(Quarterly Results - Jun 2025)
Net Profit:
34 Million
Pharmaceuticals & Biotechnology
USD 2,606 Million (Small Cap)
22.00
NA
0.00%
1.06
18.06%
2.95






